17 July 2017

A Nijmegen-based public-private partnership received 1.5 million Euro from the European Fund for Regional Development (EFRO).

With this grant, the consortium aims to develop novel therapeutics against mosquito-transmitted tropical infectious diseases, such as Malaria, dengue virus and Zika virus.

The consortium consists of the spinoff companies Protinhi Therapeutics, TropIQ Health Sciences, both based at the Novio Tech Campus, and scientists from Radboud University (dr. Martin Feiters, prof. Floris Rutjes) and Radboud University Medical Center (dr. Ronald van Rij, prof. Robert Sauerwein).

More information (in Dutch): read more.

Related news items

Grants for research on magnesium deficiency and malaria Vidis for Felix Hol and Jeroen de Baaij

1 July 2022 Radboudumc researchers Jeroen de Baaij and Felix Hol both receive an NWO Vidi grant for their research, respectively on magnesium deficiency in type 2 diabetes and on malaria.  read more

Veni grants for RIMLS researchers

16 December 2021 NWO has awarded 89 promising young scientists Veni funding of up to 280,000 euros. Three of them are from Radboud Institute of Molecular Life Sciences (RIMLS). They can develop their own research ideas over a period of three years. read more

Two science talents to foreign top institutes with Rubicon

21 June 2021 Rubicons for Michelle Brouwer and Guido van Mierlo read more

Rebecca Halbach receives idea generator grant to fight mosquito transmitted viruses

8 July 2020 Rebecca Halbach and Pascal Miesen have investigated in a collaborative project whether the treatment of mosquitoes with antiviral drugs can prevent the transmission of mosquito-transmitted viral diseases. read more

Three VIDI grants for RIMLS researchers

24 May 2019 Matthijs Jore, Daniele Tauriello and Johannes Textor are each to receive up to 800,000 euros to develop an innovative research theme and to build up their own research group. NWO is awarding the Vidi grant as part of the Innovational Research Incentives Scheme. read more

Veterinary drug can prevent outbreaks of malaria and Zika in humans

5 July 2018 Drugs that protect pets against ticks and fleas can also be used to prevent outbreaks of malaria, Zika and dengue fever in humans. This was the conclusion of an article by scientists from TropIQ Health Sciences, together with English and American colleagues, and published in the journal PNAS. read more